Workflow
BNP Paribas Primary New Issues: STAB Notice - No Stab Prelios
STATERA BIOPHARMSTATERA BIOPHARM(US:STAB) GlobeNewswire News Room·2025-05-22 16:18

Group 1 - The announcement indicates that no stabilisation was carried out in relation to the securities offer by X3G MERGECO S.P.A [2] - The aggregate nominal amount of the securities offered is EUR 360,000,000 with a coupon rate of 7% maturing in May 2030 [3] - The offer price for the securities is set at 92 [3] Group 2 - The stabilisation managers involved in the offering include BNP Paribas, Unicredit, Intesa, Banca Akros, Standard Chartered, and Mediobanca [4] - The announcement clarifies that the securities are not being offered for sale in the United States and have not been registered under the U.S. Securities Act of 1933 [5]